How many studies have been conducted on Ceftizoxime?

BiohacksAI has indexed 299 PubMed studies on Ceftizoxime, including 44 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Ceftizoxime?

The primary research domains for Ceftizoxime are 🫘 Kidney, 😴 Sleep, 🧠 Focus & Attention. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Ceftizoxime

A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.

299+ PubMed studies analyzed · 44 RCTs · Evidence Score: 49.2

Research Domains

Ceftizoxime has been studied across 12 research domains including 🫘 Kidney, 😴 Sleep, 🧠 Focus & Attention, 🫁 Respiratory, 🛡️ Immunity. The primary research focus is 🫘 Kidney with 6% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ceftizoxime is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.